NATRIUMFUSIDAT

Natriumfusidat (fusidate sodium) is a steroidal antibiotic that inhibits bacterial protein synthesis by interfering with elongation factor G. It is particularly active against staphylococci, including some resistant strains. Benefits include good tissue penetration. Side effects include cholestatic jaundice, elevated liver enzymes, GI upset, and, rarely, rash or hematologic abnormalities. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 4a8365d1f8c3 Category: Tag:

Product Description


Mechanism of Action

NATRIUMFUSIDAT exhibits a multivector biochemical action pattern, influencing enzymatic cascades, receptormediated signalling, intracellular ion behaviour, mitochondrial oxidative dynamics and transcriptional regulatory networks. Its structural characteristics suggest interaction with catalytic residues, allosteric pockets and regulatory scaffolds, enabling modulation of phosphorylation circuits, secondmessenger systems (cAMP, Ca²⁺, IP), ROS generation, membrane polarization and metabolicflux channeling.

Depending on biological context, NATRIUMFUSIDAT may alter mitochondrial membrane potential, redox buffering capacity, calcium sequestration, cytoskeletal integrity, vesicle trafficking efficiency and transcriptionfactor activation, resulting in broad mechanistic adaptability across experimental systems.

Benefits and Advantages

This compound is highly valued in advanced biochemical and pharmacological research frameworks, including:

  • Highresolution receptorligand mapping and affinity prediction
  • Enzymekinetic profiling and catalyticpathway deconstruction
  • Mitochondrialstress testing, ATPflux analysis and ROSequilibrium studies
  • Integrated multiomics research: transcriptomics, metabolomics, proteomics, phosphoproteomics
  • Cytoskeletal modelling involving actin/tubulin regulation
  • Apoptosis, autophagy, necroptosis and ferroptosis signalling investigations
  • Structureactivity relationship (SAR) exploration and molecular optimisation
  • Pharmacodynamic simulations for mechanistic threshold and doseresponse studies

Side Effects and Risks

Possible laboratoryobserved risks include:

  • Redox imbalance with elevated ROS levels
  • Mitochondrial overactivation or respiratorychain suppression
  • Ionchannel dysregulation affecting Na⁺/K⁺/Ca²⁺ flow
  • Crossactivation or inhibition of unintended receptor systems
  • Cytoskeletal destabilisation and impaired membrane integrity
  • Dosedependent cytotoxicity or induction of apoptotic/autophagic pathways
  • Transcriptional instability and activation of inflammatory cascades (NF-κB, JNK, p38)

Strict biosafety handling, controlled dosing and regulated environmental conditions are required for all experimental use. Not intended for human or veterinary application.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C31H47O6Na

Molecular Weight

538.7 g/mol

CAS Number

751-94-0

Storage Condition

Store at 2-8°C

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

(2Z)-2-[(3R,4S,8S,9R,10S,11R,13S,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid

IUPAC/Chemical Name

Sodium fusidate

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download